InsiderTrades.com logo
5 Tech Stocks to Buy Immediately
From Investor Place Media   |   Ad
Eric Fry, one of America's top Investment Strategists, provides his latest report 5 Top Stocks for 2022.

You can't afford to miss out on the once in a decade chance to buy after the recent dip in the markets.
Download this hot-off-the-presses research report now. It’s yours FREE.

CHM Insider Trading (Chimeric Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$173,886.40
Insider Selling (Last 12 Months): A$0.00

Chimeric Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Chimeric Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Chimeric Therapeutics Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 03/11/2021 11:04 AM ET

This chart shows the closing price history over time for CHM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
The Unknown Meal Delivery Company About to Rocket
From Home Bistro   |   Ad
As Q1 orders grew 198%, this player may be the next leader in the meal delivery space!
Continue Reading

Chimeric Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/4/2021George MatchamInsiderBuy500,000A$0.33A$166,000.00
3/8/2021Cynthia ElkinsInsiderBuy24,800A$0.32A$7,886.40
See Full Table
Insider Selling at Chimeric Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Chimeric Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Chimeric Therapeutics (ASX:CHM)

Chimeric Therapeutics logo
Chimeric Therapeutics Limited, a biotechnology company, develops and commercializes chimeric antigen receptor T cell therapy drugs for solid tumors in Australia. It is developing CLTX-CAR T cell therapy that is Phase I clinical study in Glioblastoma. The company was incorporated in 2020 and is based in Carlton, Australia.
Read More on Chimeric Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Chimeric Therapeutics?

Chimeric Therapeutics' top insider shareholders include:
  1. Cynthia Elkins (Insider)
  2. George Matcham (Insider)
The World's First Celebrity Chef Meal Platform is Here
From Home Bistro   |   Ad
This emerging company has one of the most unique online meal services ever. Learn more.
Continue Reading